News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Scott Blackman

Mr Blackman is the Director of Market Access at BrainsWay.

Articles by Scott Blackman

tms

Achieving OCD Relief: Consideration of TMS Earlier in the Treatment Continuum

ByAron Tendler, MD,Scott Blackman

April 11th 2023

Here’s why TMS is a treatment option to consider in obsessive-compulsive disorder.

Latest Updated Articles

Achieving OCD Relief: Consideration of TMS Earlier in the Treatment Continuum
Published: April 11th 2023 | Updated:

Trending on Psychiatric Times

Lecanemab or Lithium for Alzheimer Disease Dementia? New Data Change Everything

Planned FDA Investigational New Drug Application: SPC-15 for the Treatment of PTSD

Toward a Spiritual Psychiatry Subspecialty

ADHD: Correcting Careless Myths

Tonmya Available Commercially for Treatment of Fibromyalgia

© 2025 MJH Life Sciences^®

All rights reserved.